Altria Group Inc

Altria Group Inc（MO）资讯与事件

$68.650

+0.995 (+1.45%)收盘时

MO 资讯

Altria Group Welcomes New Board Member Steven W. Presley
5.008-28Newsfilter

Altria Group Welcomes New Board Member Steven W. Presley

Altria Group Increases Quarterly Dividend by 4.7%
8.008-27Newsfilter

Altria Group Increases Quarterly Dividend by 4.7%

Steel Manufacturers Rise After Trade Negotiations Collapse
2.008-24CNBC

Steel Manufacturers Rise After Trade Negotiations Collapse

Altria and Philip Morris Enter Manufacturing Agreement
7.508-24Newsfilter

Altria and Philip Morris Enter Manufacturing Agreement

Blueprint for Building $19,000 Monthly Dividend Income
2.008-23Yahoo Finance

Blueprint for Building $19,000 Monthly Dividend Income

查看更多资讯

MO 事件

8/28 14:30

FDA Authorizes JUUL2 E-Cigarette Products for Marketing

The U.S. Food and Drug Administration authorized the marketing of three new e-cigarette products through the premarket tobacco product application pathway. The authorized products are part of the JUUL2 e-cigarette system made by JUUL Labs, which is 35% owned by Altria (M), and include a tobacco-flavored pod, a menthol-flavored pod, and the JUUL2 device. As part of its thorough scientific review of new tobacco products, the FDA considers the risks and benefits to the U.S. population as a whole - including the benefits to adults who currently use tobacco products and switch to a potentially lower-risk product, as well as the risks posed to youth and non-users of tobacco products. To receive marketing authorizations, the FDA must have sufficient evidence that the new products offer greater benefits to population health than risks. The FDA's review of data in the application found that a substantial proportion of adults who smoke completely switched away from combustible cigarettes to the authorized JUUL2 products, with the menthol-flavored pod having a higher rate of complete switching compared to the tobacco-flavored pod. Specifically, 19.9 to 34.6% of those using the tobacco-flavored pod and 28.4 to 49.3% of those using the menthol-flavored pod stopped smoking cigarettes entirely at six weeks. Those who completely switched to the authorized products were exposed to lower levels of harmful chemicals than they would have been had they continued smoking cigarettes. The FDA determined that the added benefit to adults who smoke cigarettes is sufficient to outweigh the risks of the menthol-flavored product, including youth appeal. Other publicly traded companies in the space include British American Tobacco (BTI), Imperial Brands (IMBBY) and Philip Morris (PM).

8/28 07:30

Altria Group Appoints Steven Presley to Board of Directors

Altria Group announces that Steven Presley joined our Board of Directors on August 27, 2026. Presley is Chief Executive Officer of Refresco Benelux B.V.

8/27 15:30

Altria Group Increases Quarterly Dividend to $1.11 per Share

Altria Group announced that its Board of Directors voted to increase its regular quarterly dividend by 4.7% to $1.11 per share versus the previous rate of $1.06 per share. The quarterly dividend is payable on October 9, 2026 to shareholders of record as of September 15, 2026. The new annualized dividend rate is $4.44 per share, representing a dividend yield of 6.4% based on the closing stock price of $69.12 on August 26, 2026.

查看更多事件

本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始